Nathaniel Fernhoff

Company: Orca Bio

Job title: Co-Founder & CSO

Seminars:

Harnessing the Power of Regulatory T cells for Orca-T: a High-Precision Cell Immunotherapy for AML, MDS & ALL 11:30 am

Orca Bio is an allogeneic cell therapy company developing high-precision cell immunotherapies for hematological malignancies and autoimmune disorders Orca-T, Orca Bio’s lead investigational product, is a cell therapy that leverages highly purified regulatory T cells to control immune reconstitution. It’s currently being tested in a pivotal Phase 3 study, Precision-T Orca-T is intended to reduce…Read more

day: Day Two AM Cell-Based Approaches